drugset / Trial / NCT00378144

Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold

NCT00378144

Phase 4 Completed 469 enrolled McNeil AB
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the efficacy and safety for a marketed sinus allergy product, Sinutab, in the treatment of nasal congestion and headache.

Timeline

Start
2007-01
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg Oral
Subject Pseudoephedrine Small molecule 30 mg Oral